Patents Assigned to Maryland Mental Health Institute, LLC
  • Treatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin
    Patent number: 10828348
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilii and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilii and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: November 10, 2020
    Assignee: Maryland Mental Health Institute, LLC
    Inventors: Eric Finzi, Norman E. Rosenthal
  • Method of treating depression
    Patent number: 10751395
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: August 25, 2020
    Assignee: Maryland Mental Health Institute, LLC
    Inventor: Eric Finzi